FI972185A0 - Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon - Google Patents
Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoonInfo
- Publication number
- FI972185A0 FI972185A0 FI972185A FI972185A FI972185A0 FI 972185 A0 FI972185 A0 FI 972185A0 FI 972185 A FI972185 A FI 972185A FI 972185 A FI972185 A FI 972185A FI 972185 A0 FI972185 A0 FI 972185A0
- Authority
- FI
- Finland
- Prior art keywords
- treatment
- insulin
- aminoguanidine
- carboxylate
- diabetes mellitus
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- -1 Aminoguanidine carboxylate Chemical class 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34427494A | 1994-11-23 | 1994-11-23 | |
| US08/484,547 US5994577A (en) | 1994-11-23 | 1995-06-07 | Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
| PCT/US1995/014126 WO1996016031A1 (en) | 1994-11-23 | 1995-11-13 | Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI972185A FI972185A (fi) | 1997-05-22 |
| FI972185A0 true FI972185A0 (fi) | 1997-05-22 |
Family
ID=26993832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI972185A FI972185A0 (fi) | 1994-11-23 | 1997-05-22 | Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6166080A (fi) |
| EP (1) | EP0793646B1 (fi) |
| JP (1) | JPH10509455A (fi) |
| CN (2) | CN1097580C (fi) |
| AT (1) | ATE205188T1 (fi) |
| AU (1) | AU705893B2 (fi) |
| BR (1) | BR9509741A (fi) |
| CA (1) | CA2202265A1 (fi) |
| CZ (1) | CZ288597B6 (fi) |
| DE (2) | DE793646T1 (fi) |
| DK (1) | DK0793646T3 (fi) |
| EE (1) | EE03392B1 (fi) |
| ES (1) | ES2163531T3 (fi) |
| FI (1) | FI972185A0 (fi) |
| GE (1) | GEP20002026B (fi) |
| HU (1) | HUT77133A (fi) |
| MX (1) | MX9703807A (fi) |
| NO (1) | NO308992B1 (fi) |
| NZ (1) | NZ297604A (fi) |
| PL (1) | PL184614B1 (fi) |
| PT (1) | PT793646E (fi) |
| RU (1) | RU2162462C2 (fi) |
| SK (1) | SK282357B6 (fi) |
| WO (1) | WO1996016031A1 (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9526331D0 (en) * | 1995-12-22 | 1996-02-21 | Smithkline Beecham Plc | Novel method |
| AU3117497A (en) | 1996-05-21 | 1997-12-09 | Pharmacia & Upjohn Company | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| CA2280871A1 (en) * | 1997-02-13 | 1998-08-20 | Valerie Piercy | Use of nitric oxide synthase inhibitors for the treatment of diabetes |
| SE9702457D0 (sv) * | 1997-06-26 | 1997-06-26 | Pharmacia & Upjohn Ab | Screening |
| US6001578A (en) * | 1997-06-26 | 1999-12-14 | Pharmacia & Upjohn Ab | Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity |
| US6288124B1 (en) | 1998-05-22 | 2001-09-11 | Rima Kaddurah-Daouk | Methods of inhibiting undesirable cell growth using an aminoguanidine compound |
| US6169115B1 (en) | 1998-05-22 | 2001-01-02 | Rima Kaddurah-Daouk | Use of aminoguanidine analogs for the treatment of diseases of the nervous system |
| US6815421B1 (en) * | 2001-03-22 | 2004-11-09 | Osteopharm Inc. | Polypeptides for use in ameliorating effects of aging in mammals |
| US8871527B2 (en) * | 2008-04-29 | 2014-10-28 | Becton, Dickinson And Company | Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition |
| MX2011000135A (es) * | 2008-06-26 | 2011-02-25 | Silanes Sa De Cv Lab | Una nueva sal de glicinato de metformina para el control de la glucosa en sangre. |
| GB201300435D0 (en) * | 2013-01-10 | 2013-02-27 | Medical Res Council | Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases |
| CN106661422B (zh) * | 2015-04-23 | 2018-10-09 | 三菱瓦斯化学株式会社 | 气体发生剂以及使用该气体发生剂的发泡体的制造方法 |
| US20170056352A1 (en) * | 2015-08-25 | 2017-03-02 | Rgenix, Inc. | PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF |
| WO2018160178A1 (en) | 2017-03-01 | 2018-09-07 | Rgenix, Inc. | Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof |
| CA3161341A1 (en) | 2019-12-11 | 2021-06-17 | Masoud Fakhr Tavazoie | Methods of treating cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3412105A (en) | 1966-01-05 | 1968-11-19 | American Home Prod | beta-aryl-n-guanidino-beta-alanines |
| US3943253A (en) * | 1974-06-27 | 1976-03-09 | Barer Sol J | Guanido acids as fungicides |
| JPS54128523A (en) | 1978-03-29 | 1979-10-05 | Nippon Carbide Ind Co Ltd | 3-guanidinoamino propionic acid and its preparation |
| US5130324A (en) * | 1984-03-19 | 1992-07-14 | The Rockefeller University | 2-alkylidene-aminoguanidines and methods of use therefor |
| US5272165A (en) * | 1984-03-19 | 1993-12-21 | The Rockefeller University | 2-alkylidene-aminoguanidines and methods of use therefor |
| US4758583A (en) * | 1984-03-19 | 1988-07-19 | The Rockefeller University | Method and agents for inhibiting protein aging |
| IT1201511B (it) | 1985-12-23 | 1989-02-02 | Italfarmaco Spa | Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono |
| US5059712A (en) | 1989-09-13 | 1991-10-22 | Cornell Research Foundation, Inc. | Isolating aminoarginine and use to block nitric oxide formation in body |
| GB9200114D0 (en) | 1992-01-04 | 1992-02-26 | Scras | Dual inhibitors of no synthase and cyclooxygenase |
-
1995
- 1995-11-08 DE DE0793646T patent/DE793646T1/de active Pending
- 1995-11-08 PT PT95939672T patent/PT793646E/pt unknown
- 1995-11-13 SK SK640-97A patent/SK282357B6/sk unknown
- 1995-11-13 NZ NZ297604A patent/NZ297604A/en unknown
- 1995-11-13 JP JP8516882A patent/JPH10509455A/ja not_active Ceased
- 1995-11-13 PL PL95320361A patent/PL184614B1/pl unknown
- 1995-11-13 HU HU9701701A patent/HUT77133A/hu unknown
- 1995-11-13 US US08/952,717 patent/US6166080A/en not_active Expired - Fee Related
- 1995-11-13 RU RU97110081/04A patent/RU2162462C2/ru not_active IP Right Cessation
- 1995-11-13 BR BR9509741A patent/BR9509741A/pt not_active Application Discontinuation
- 1995-11-13 CA CA002202265A patent/CA2202265A1/en not_active Abandoned
- 1995-11-13 CN CN95196384A patent/CN1097580C/zh not_active Expired - Fee Related
- 1995-11-13 DE DE69522580T patent/DE69522580T2/de not_active Expired - Fee Related
- 1995-11-13 AT AT95939672T patent/ATE205188T1/de not_active IP Right Cessation
- 1995-11-13 ES ES95939672T patent/ES2163531T3/es not_active Expired - Lifetime
- 1995-11-13 AU AU42796/96A patent/AU705893B2/en not_active Ceased
- 1995-11-13 WO PCT/US1995/014126 patent/WO1996016031A1/en active IP Right Grant
- 1995-11-13 MX MX9703807A patent/MX9703807A/es unknown
- 1995-11-13 CZ CZ19971369A patent/CZ288597B6/cs not_active IP Right Cessation
- 1995-11-13 EP EP95939672A patent/EP0793646B1/en not_active Expired - Lifetime
- 1995-11-13 EE EE9700094A patent/EE03392B1/xx not_active IP Right Cessation
- 1995-11-13 DK DK95939672T patent/DK0793646T3/da active
- 1995-11-13 GE GEAP19953797A patent/GEP20002026B/en unknown
-
1997
- 1997-05-22 FI FI972185A patent/FI972185A0/fi unknown
- 1997-05-22 NO NO972346A patent/NO308992B1/no unknown
-
1999
- 1999-11-08 US US09/435,717 patent/US6329545B1/en not_active Expired - Fee Related
-
2002
- 2002-04-10 CN CN02106295A patent/CN1377642A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972185A0 (fi) | Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon | |
| ATE131863T1 (de) | Verwendung von halogenkohlenwasserstofflösungsmittel als reinigungsmittel | |
| MX9704377A (es) | Uso de pramipexole como agente neuroprotector. | |
| AU6613896A (en) | Chemical compounds | |
| AU2618292A (en) | Novel 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines | |
| AU2618392A (en) | Novel 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines | |
| GB9201857D0 (en) | Novel compound | |
| EP0369262A3 (en) | Novel pyrroles | |
| FI942313A (fi) | Välituote atsitromysiiniä varten | |
| DE69432140D1 (de) | Verfahren zur Herstellung von 9-Desoxotaxanen | |
| AU3869793A (en) | 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors | |
| EP0330041A3 (de) | Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| PT722319E (pt) | Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose | |
| FI951511A0 (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
| GB9206768D0 (en) | New compounds for use in the treatment of cancer | |
| AU648285B2 (en) | Coating material, process for producing it and its use | |
| ATE222762T1 (de) | 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus | |
| ATE196631T1 (de) | Xamonelin-tartrat | |
| GR3036241T3 (en) | METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES. | |
| DE59108566D1 (de) | Heteroarylmethylbenzole-Aromatasehemmer | |
| SE9700706D0 (sv) | Process for the preparation of benzothiazoline compounds | |
| DE59503443D1 (de) | Fungizide mischungen | |
| ES8601226A1 (es) | Procedimiento para preparar fenoxialquilfosfinatos y fosfonatos | |
| AU3854097A (en) | Thienylcyclohexane derivatives for thienylcyclohexyl synthesis | |
| FI972675A0 (fi) | 3,3-(disubstituoitu)sykloheksan-1-oni-monomeerejä ja vastaavia yhdisteitä |